-
Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation details
Authors:
Trang Quynh Nguyen,
Benjamin Ackerman,
Ian Schmid,
Stephen R. Cole,
Elizabeth A. Stuart
Abstract:
Background: Randomized controlled trials are often used to inform policy and practice for broad populations. The average treatment effect (ATE) for a target population, however, may be different from the ATE observed in a trial if there are effect modifiers whose distribution in the target population is different that from that in the trial. Methods exist to use trial data to estimate the target p…
▽ More
Background: Randomized controlled trials are often used to inform policy and practice for broad populations. The average treatment effect (ATE) for a target population, however, may be different from the ATE observed in a trial if there are effect modifiers whose distribution in the target population is different that from that in the trial. Methods exist to use trial data to estimate the target population ATE, provided the distributions of treatment effect modifiers are observed in both the trial and target population -- an assumption that may not hold in practice.
Methods: The proposed sensitivity analyses address the situation where a treatment effect modifier is observed in the trial but not the target population. These methods are based on an outcome model or the combination of such a model and weighting adjustment for observed differences between the trial sample and target population. They accommodate several types of outcome models: linear models (including single time outcome and pre- and post-treatment outcomes) for additive effects, and models with log or logit link for multiplicative effects. We clarify the methods' assumptions and provide detailed implementation instructions.
Illustration: We illustrate the methods using an example generalizing the effects of an HIV treatment regimen from a randomized trial to a relevant target population.
Conclusion: These methods allow researchers and decision-makers to have more appropriate confidence when drawing conclusions about target population effects.
△ Less
Submitted 25 November, 2020;
originally announced November 2020.
-
Generalizing Randomized Trial Findings to a Target Population using Complex Survey Population Data
Authors:
Benjamin Ackerman,
Catherine R. Lesko,
Juned Siddique,
Ryoko Susukida,
Elizabeth A. Stuart
Abstract:
Randomized trials are considered the gold standard for estimating causal effects. Trial findings are often used to inform policy and programming efforts, yet their results may not generalize well to a relevant target population due to potential differences in effect moderators between the trial and population. Statistical methods have been developed to improve generalizability by combining trials…
▽ More
Randomized trials are considered the gold standard for estimating causal effects. Trial findings are often used to inform policy and programming efforts, yet their results may not generalize well to a relevant target population due to potential differences in effect moderators between the trial and population. Statistical methods have been developed to improve generalizability by combining trials and population data, and weighting the trial to resemble the population on baseline covariates.Large-scale surveys in fields such as health and education with complex survey designs are a logical source for population data; however, there is currently no best practice for incorporating survey weights when generalizing trial findings to a complex survey. We propose and investigate ways to incorporate survey weights in this context. We examine the performance of our proposed estimator in simulations by comparing its performance to estimators that ignore the complex survey design.We then apply the methods to generalize findings from two trials - a lifestyle intervention for blood pressure reduction and a web-based intervention to treat substance use disorders - to their respective target populations using population data from complex surveys. The work highlights the importance in properly accounting for the complex survey design when generalizing trial findings to a population represented by a complex survey sample.
△ Less
Submitted 2 April, 2020; v1 submitted 16 March, 2020;
originally announced March 2020.
-
Transportability of Outcome Measurement Error Correction: from Validation Studies to Intervention Trials
Authors:
Benjamin Ackerman,
Juned Siddique,
Elizabeth A. Stuart
Abstract:
Many lifestyle intervention trials depend on collecting self-reported outcomes, like dietary intake, to assess the intervention's effectiveness. Self-reported outcome measures are subject to measurement error, which could impact treatment effect estimation. External validation studies measure both self-reported outcomes and an accompanying biomarker, and can therefore be used for measurement error…
▽ More
Many lifestyle intervention trials depend on collecting self-reported outcomes, like dietary intake, to assess the intervention's effectiveness. Self-reported outcome measures are subject to measurement error, which could impact treatment effect estimation. External validation studies measure both self-reported outcomes and an accompanying biomarker, and can therefore be used for measurement error correction. Most validation data, though, are only relevant for outcomes under control conditions. Statistical methods have been developed to use external validation data to correct for outcome measurement error under control, and then conduct sensitivity analyses around the error under treatment to obtain estimates of the corrected average treatment effect. However, an assumption underlying this approach is that the measurement error structure of the outcome is the same in both the validation sample and the intervention trial, so that the error correction is transportable to the trial. This may not always be a valid assumption to make. In this paper, we propose an approach that adjusts the validation sample to better resemble the trial sample and thus leads to more transportable measurement error corrections. We also formally investigate when bias due to poor transportability may arise. Lastly, we examine the method performance using simulation, and illustrate them using PREMIER, a multi-arm lifestyle intervention trial measuring self-reported sodium intake as an outcome, and OPEN, a validation study that measures both self-reported diet and urinary biomarkers.
△ Less
Submitted 2 April, 2020; v1 submitted 24 July, 2019;
originally announced July 2019.
